Literature DB >> 26547285

Risk factors for venous thromboembolism after pediatric trauma.

Casey J Allen1, Clark R Murray1, Jonathan P Meizoso1, Juliet J Ray1, Holly L Neville2, Carl I Schulman1, Nicholas Namias1, Juan E Sola2, Kenneth G Proctor3.   

Abstract

BACKGROUND/
PURPOSE: The purposes of this study were to identify independent predictors of venous thromboembolism (VTE), to evaluate the relative impact of adult VTE risk factors, and to identify a pediatric population at high-risk for VTE after trauma.
METHODS: 1934 consecutive pediatric admissions (≤ 17 years) from 01/2000 to 12/2012 at a level 1 trauma center were reviewed. Logistic regression was used to identify predictors of VTE.
RESULTS: Twenty-two patients (1.2%) developed a VTE, including 5% of those requiring orthopedic surgery, 14% of those with major vascular injury (MVI), and 36% of those with both. Most (84%) were diagnosed at the primary site of injury. 86% of those who developed a VTE were receiving thromboprophylaxis at the time of diagnosis. Independent predictors were age (odds ratio (OR): 1.59, 95% confidence interval (CI): 1.11-2.25), orthopedic surgery (OR: 8.10, CI: 3.10-21.39), transfusion (OR: 3.37, CI: 1.26-8.99), and MVI (OR: 15.43, CI: 5.70-41.76). When known risk factors for VTE in adults were adjusted, significant factors were age ≥ 13 years (OR: 9.16, CI: 1.08-77.89), indwelling central venous catheter (OR: 4.41, CI: 1.31-14.82), orthopedic surgery (OR: 6.80, CI: 2.47-18.74), and MVI (OR: 14.41, CI: 4.60-45.13).
CONCLUSION: MVI and orthopedic surgery are synergistic predictors of pediatric VTE. Most children who developed a VTE were receiving thromboprophylaxis at the time of diagnosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children; DVT; Deep vein thrombosis; Pediatrics; Trauma; VTE

Mesh:

Substances:

Year:  2015        PMID: 26547285     DOI: 10.1016/j.jpedsurg.2015.10.033

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Incidence of venous thromboembolism in hospitalized pediatric neurosurgical patients: a retrospective 25-year institutional experience.

Authors:  Mason A Brown; Daniel H Fulkerson
Journal:  Childs Nerv Syst       Date:  2019-11-05       Impact factor: 1.475

2.  Association of Blood Component Ratios With 24-Hour Mortality in Injured Children Receiving Massive Transfusion.

Authors:  Elissa K Butler; Brianna M Mills; Saman Arbabi; Eileen M Bulger; Monica S Vavilala; Jonathan I Groner; Lynn G Stansbury; John R Hess; Frederick P Rivara
Journal:  Crit Care Med       Date:  2019-07       Impact factor: 7.598

3.  Multicenter Review of Current Practices Associated With Venous Thromboembolism Prophylaxis in Pediatric Patients After Trauma.

Authors:  Amee M Bigelow; Katherine T Flynn-O'Brien; Pippa M Simpson; Mahua Dasgupta; Sheila J Hanson
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

Review 4.  Venous thromboembolism prophylaxis after pediatric trauma.

Authors:  Christina Georgeades; Kyle Van Arendonk; David Gourlay
Journal:  Pediatr Surg Int       Date:  2021-01-19       Impact factor: 1.827

5.  Obesity in pediatric trauma.

Authors:  Cordelie E Witt; Saman Arbabi; Avery B Nathens; Monica S Vavilala; Frederick P Rivara
Journal:  J Pediatr Surg       Date:  2016-11-23       Impact factor: 2.545

6.  Venous thromboembolism risk factors in a pediatric trauma population.

Authors:  Louis A Carrillo; Akshita Kumar; Matthew T Harting; Claudia Pedroza; Charles S Cox
Journal:  Pediatr Surg Int       Date:  2018-11-19       Impact factor: 1.827

Review 7.  Venous Thromboembolism in Critical Illness and Trauma: Pediatric Perspectives.

Authors:  Ranjit S Chima; Sheila J Hanson
Journal:  Front Pediatr       Date:  2017-03-13       Impact factor: 3.418

8.  Venous thromboembolism following inpatient pediatric surgery: Analysis of 153,220 patients.

Authors:  Brandon A Sherrod; Samuel G McClugage; Vincent E Mortellaro; Inmaculada B Aban; Brandon G Rocque
Journal:  J Pediatr Surg       Date:  2018-10-10       Impact factor: 2.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.